Personalized Autologous Vaccines Activate Stimulator of Interferon Gene and Suppress Dendritic Cell Programmed Death Ligand 1 to Potentiate Antitumor Immunity
ACS Nano · 11.08.2026 · 20 (31) · 21752-21766
DOI: 10.1021/acsnano.6c03725 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 24.07.2026. Verfasst von Zhijuan Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutic Sciences, Faculty of Science, National University of Singapore, Singapore117543, Singapore. Hauptthemen laut MEDLINE: Cancer Vaccines, B7-H1 Antigen, Dendritic Cells, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National University of Singapore, Singapore Ministry of Education, Singapore National Medical Research Council.
Abstract (Originalsprache)
Cancer vaccines have underperformed clinically, largely because antigen-specific CTL priming and expansion are constrained by insufficient costimulatory activation and increased DC-mediated coinhibition. Here, we present a personalized cancer vaccine platform, STAR, which engineers stimulator of interferon gene (STING)-activating autologous tumor-derived microvesicles (TMVs) to concurrently amplify costimulatory signaling and relieve DC coinhibition during antigen cross-presentation. TMVs provide broad tumor antigen cargo and intrinsic STING activity; loading manganese phosphate nanoparticles (MnPs) potentiates cGAS-STING signaling, drives DC maturation, and enhances antigen cross-presentation. Importantly, concurrent delivery of PD-L1-targeting siRNA (siPD-L1) effectively inhibits DC-associated PD-L1, freeing CD80 to engage CD28 and limiting PD-1/PD-L1 signaling and thereby significantly enhancing antigen-specific CD8+ T cells. In mouse models, STAR vaccination elicited durable prophylactic immunity and achieved substantial therapeutic efficacy against melanoma and colorectal tumors without additional immunotherapies. Notably, patient-specific STAR vaccines derived from surgically resected tumors effectively prevented postoperative recurrence and metastasis in aggressive melanoma and triple-negative breast cancer models, thereby highlighting their translational potential. Overall, the STAR vaccine platform offers a versatile and clinically applicable approach to enhancing personalized cancer immunotherapy across diverse cancer types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy and Pharmaceutic Sciences, Faculty of Science, National University of Singapore, Singapore117543, Singapore.
- Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore119074, Singapore.
- Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore117543, Singapore.
- Nanomedicine Translational Research Programme, NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore117597, Singapore.
- Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore138648, Singapore.
ORCID-Profile: Lingwen Ding, Min Luo, Wei Tang
Förderung
- National University of Singapore
- Singapore Ministry of Education
- Singapore National Medical Research Council
Zitieren
APA
Yang, Z., Han, H., Zhao, Z., Ding, L., Xu, X., Ma, M., Luo, M., & Tang, W. (2026). Personalized Autologous Vaccines Activate Stimulator of Interferon Gene and Suppress Dendritic Cell Programmed Death Ligand 1 to Potentiate Antitumor Immunity. ACS Nano, 20(31), 21752-21766. https://doi.org/10.1021/acsnano.6c03725
Vancouver
Yang Z, Han H, Zhao Z, Ding L, Xu X, Ma M, et al. Personalized Autologous Vaccines Activate Stimulator of Interferon Gene and Suppress Dendritic Cell Programmed Death Ligand 1 to Potentiate Antitumor Immunity. ACS Nano. 2026;20(31):21752-21766. doi:10.1021/acsnano.6c03725
BibTeX
@article{Yang2026,
author = {Yang, Zhijuan and Han, Huize and Zhao, Zhihao and Ding, Lingwen and Xu, Xin and Ma, Muye and Luo, Min and Tang, Wei},
title = {Personalized Autologous Vaccines Activate Stimulator of Interferon Gene and Suppress Dendritic Cell Programmed Death Ligand 1 to Potentiate Antitumor Immunity},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {31},
pages = {21752--21766},
doi = {10.1021/acsnano.6c03725}
}
EUVIMED